Skip to content

Ginkgo Bioworks DNA Other intangible assets—net

Other intangible assets—net at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$37.46M-9.1%
Sana Biotechnology logo
Sana BiotechnologySANA
$59.2M0.0%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$144.89M-27.4%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
TEC
Bio-TechneTECH
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's other intangible assets—net?
Ginkgo Bioworks (DNA) reported other intangible assets—net of $48.86M in Q1 2026.
How has Ginkgo Bioworks's other intangible assets—net changed year-over-year?
Ginkgo Bioworks's other intangible assets—net decreased by 28.9% year-over-year, from $68.76M to $48.86M.
What is the long-term trend for Ginkgo Bioworks's other intangible assets—net?
Over 5 years (2020 to 2025), Ginkgo Bioworks's other intangible assets—net has grown at a 74.6% compound annual growth rate (CAGR), from $3.29M to $53.48M.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.